Valuation: DexCom, Inc.

Capitalization 3.33TCr 2.84TCr 2.65TCr 2.45TCr 4.56TCr 2,85300Cr 5.1TCr 32TCr 12TCr 1,33300Cr 12TCr 12TCr 4,87700Cr P/E ratio 2025 *
43.7x
P/E ratio 2026 * 34.1x
Enterprise value 3.47TCr 2.97TCr 2.76TCr 2.56TCr 4.76TCr 2,97600Cr 5.32TCr 33TCr 13TCr 1,39000Cr 13TCr 13TCr 5,08800Cr EV / Sales 2025 *
7.53x
EV / Sales 2026 * 6.28x
Free-Float
95.22%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.33%
1 week+1.54%
Current month-2.77%
1 month-2.08%
3 months+39.84%
6 months+5.97%
Current year+9.13%
More quotes
1 week 82.5
Extreme 82.5
85.2
1 month 77.81
Extreme 77.81
88.32
Current year 57.52
Extreme 57.52
93.25
1 year 57.52
Extreme 57.52
117.19
3 years 57.52
Extreme 57.52
142
5 years 57.52
Extreme 57.52
164.86
10 years 10.66
Extreme 10.655
164.86
More quotes
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 45 19/03/2021
President 46 09/05/2025
Director TitleAgeSince
Chairman 67 30/07/2018
Director/Board Member 66 20/11/2009
Director/Board Member 63 07/11/2013
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.33%+1.54%-23.52%+4.47% 3.28TCr
-0.10%-2.23%+30.45%+21.93% 23TCr
+0.47%+0.28%+15.83%-0.54% 11TCr
+0.71%+1.64%+34.19%+110.56% 5.78TCr
+0.50%-1.22%-22.19%-28.56% 5.01TCr
+1.09%+3.45%-11.96%+41.19% 3.98TCr
+0.92%-4.67%-9.45%+19.05% 2.47TCr
-0.50%-1.52%+27.48%-40.37% 2.29TCr
-0.55%-4.69%+5.21%+10.45% 2.29TCr
+0.32%-0.84%+49.73%+26.30% 2.09TCr
Average +0.42%-1.13%+9.58%+16.45% 6.17TCr
Weighted average by Cap. +0.31%-0.88%+16.25%+19.60%
See all sector performances

Financials

2025 *2026 *
Net sales 461.15Cr 393.92Cr 367.1Cr 339.51Cr 631.88Cr 40TCr 706.39Cr 4.39TCr 1.67TCr 18TCr 1.73TCr 1.69TCr 68TCr 531.83Cr 454.29Cr 423.36Cr 391.55Cr 728.73Cr 46TCr 814.66Cr 5.07TCr 1.93TCr 21TCr 1.99TCr 1.95TCr 78TCr
Net income 78Cr 66Cr 62Cr 57Cr 106.66Cr 6.67TCr 119.23Cr 741.61Cr 282.18Cr 3.12TCr 291.96Cr 285.92Cr 11TCr 100Cr 85Cr 79Cr 73Cr 136.47Cr 8.54TCr 152.56Cr 948.89Cr 361.05Cr 3.99TCr 373.56Cr 365.83Cr 15TCr
Net Debt 144.02Cr 123.02Cr 114.64Cr 106.03Cr 197.34Cr 12TCr 220.61Cr 1.37TCr 522.1Cr 5.77TCr 540.18Cr 529.01Cr 21TCr 15Cr 12Cr 12Cr 11Cr 20Cr 1.25TCr 22Cr 138.92Cr 53Cr 583.98Cr 55Cr 54Cr 2.14TCr
More financial data * Estimated data
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.7% of net sales.
Employees
10,250
More about the company
Date Price Change Volume
09/25/09 84.87 $ +1.33% 26,92,919
08/25/08 83.76 $ +0.99% 30,37,999
07/25/07 82.94 $ +0.01% 27,82,495
03/25/03 82.93 $ -0.78% 18,41,055
02/25/02 83.58 $ 0.00% 28,67,130

Delayed Quote Nasdaq, July 10, 2025 at 01:30 am IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
84.87USD
Average target price
98.59USD
Spread / Average Target
+16.16%
Consensus

Quarterly revenue - Rate of surprise